<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR3">
 <label>3.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Dow</surname>
    <given-names>DE</given-names>
   </name>
   <name>
    <surname>Bartlett</surname>
    <given-names>JA</given-names>
   </name>
  </person-group>
  <article-title>Dolutegravir, the second-generation of integrase strand transfer inhibitors (INSTIs) for the treatment of HIV</article-title>
  <source>Infect Dis Ther.</source>
  <year>2014</year>
  <volume>3</volume>
  <issue>2</issue>
  <fpage>83</fpage>
  <lpage>102</lpage>
  <pub-id pub-id-type="doi">10.1007/s40121-014-0029-7</pub-id>
  <pub-id pub-id-type="pmid">25134686</pub-id>
 </element-citation>
</ref>
